Source: Markets Insider

Blade Therapeutics: Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business Combination

Extraordinary General Meeting of BAC's shareholders postponed until a to-be-determined later dateNEW YORK and SOUTH SAN FRANCISCO, Calif., June 2,...

Read full article »
Blade Therapeutics's Competitors | Blade Therapeutics's News | Blade Therapeutics's Financials
Stay up-to-date with the latest news on Blade Therapeutics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Wendye Robbins's photo - President & CEO of Blade Therapeutics

President & CEO

Wendye Robbins

CEO Approval Rating

97/100

Read more
Stay up-to-date with the latest news on Blade Therapeutics